Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS

Abstract

Patterns of inflammation at the time of PML diagnosis and at the PML-IRIS stage overlap but differ in their severity of inflammation. This supports histopathological evidence that the inflammation seen at both stages of the same disease shares a similar underlying pathophysiology, representing the immune response to the JC virus to a variable extend.